These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28574599)

  • 41. [Expression and clinical significance of COX-2, p-Stat3, and p-Stat5 in esophageal carcinoma].
    Liu JR; Wang Y; Zuo LF; Li FL; Wang Y; Liu JL
    Ai Zheng; 2007 May; 26(5):458-62. PubMed ID: 17672932
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PTP1B contributes to calreticulin-induced metastatic phenotypes in esophageal squamous cell carcinoma.
    Wang XM; Shang L; Zhang Y; Hao JJ; Shi F; Luo W; Zhang TT; Wang BS; Yang Y; Liu ZH; Zhan QM; Wang MR
    Mol Cancer Res; 2013 Sep; 11(9):986-94. PubMed ID: 23814025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma.
    Zhang HF; Chen Y; Wu C; Wu ZY; Tweardy DJ; Alshareef A; Liao LD; Xue YJ; Wu JY; Chen B; Xu XE; Gopal K; Gupta N; Li EM; Xu LY; Lai R
    Clin Cancer Res; 2016 Feb; 22(3):691-703. PubMed ID: 26405196
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.
    Islam F; Gopalan V; Law S; Tang JC; Chan KW; Lam AK
    Hum Pathol; 2017 Apr; 62():141-151. PubMed ID: 28188753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low expression of BEX1 predicts poor prognosis in patients with esophageal squamous cell cancer.
    Geng HT; Cheng ZW; Cao RJ; Wang ZB; Xing SZ; Guo C; Wang F; Liu CM; Chen SS; Cheng YF
    Oncol Rep; 2018 Nov; 40(5):2778-2787. PubMed ID: 30132532
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stat3 promotes invasion of esophageal squamous cell carcinoma through up-regulation of MMP2.
    Xuan X; Li S; Lou X; Zheng X; Li Y; Wang F; Gao Y; Zhang H; He H; Zeng Q
    Mol Biol Rep; 2015 May; 42(5):907-15. PubMed ID: 25407307
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Flotillin-1 promotes tumor necrosis factor-α receptor signaling and activation of NF-κB in esophageal squamous cell carcinoma cells.
    Song L; Gong H; Lin C; Wang C; Liu L; Wu J; Li M; Li J
    Gastroenterology; 2012 Oct; 143(4):995-1005.e12. PubMed ID: 22732732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. STAT3-EphA7 axis contributes to the progression of esophageal squamous cell carcinoma.
    Wang L; Zhao QF; Yang BB; Liang HJ; Zhang XE; Zhang XY; Yang WJ; Guo ZY; Xu X; Tian F; Wu QH
    Acta Oncol; 2023 Dec; 62(12):1757-1766. PubMed ID: 37738252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-615-5p targets insulin-like growth factor 2 and exerts tumor-suppressing functions in human esophageal squamous cell carcinoma.
    Yang B; Xie R; Wu SN; Gao CC; Yang XZ; Zhou JF
    Oncol Rep; 2018 Jan; 39(1):255-263. PubMed ID: 29115555
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CXCL6 fuels the growth and metastases of esophageal squamous cell carcinoma cells both in vitro and in vivo through upregulation of PD-L1 via activation of STAT3 pathway.
    Zheng S; Shen T; Liu Q; Liu T; Tuerxun A; Zhang Q; Yang L; Han X; Lu X
    J Cell Physiol; 2021 Jul; 236(7):5373-5386. PubMed ID: 33368292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
    Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
    Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway.
    Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P
    Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PTPLAD2 is a tumor suppressor in esophageal squamous cell carcinogenesis.
    Zhu S; Wang Z; Zhang Z; Wang J; Li Y; Yao L; Mei Q; Zhang W
    FEBS Lett; 2014 Mar; 588(6):981-9. PubMed ID: 24530685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SAMD9 Promotes Postoperative Recurrence of Esophageal Squamous Cell Carcinoma by Stimulating MYH9-Mediated GSK3β/β-Catenin Signaling.
    Li Q; Luo H; Dai FQ; Wang RT; Fan XQ; Luo YY; Deng MS; Wang Y; Long T; Guo W; Xu B; Xu CX; Jin H
    Adv Sci (Weinh); 2023 Apr; 10(11):e2203573. PubMed ID: 36757050
    [TBL] [Abstract][Full Text] [Related]  

  • 56. κ-Opioid receptor in the nucleus is a novel prognostic factor of esophageal squamous cell carcinoma.
    Zhang YF; Xu QX; Liao LD; Xu XE; Wu JY; Shen J; Wu ZY; Shen JH; Li EM; Xu LY
    Hum Pathol; 2013 Sep; 44(9):1756-65. PubMed ID: 23574786
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paclitaxel induces apoptosis of esophageal squamous cell carcinoma cells by downregulating STAT3 phosphorylation at Ser727.
    Zhang X; Wu X; Zhang F; Mo S; Lu Y; Wei W; Chen X; Lan L; Lu B; Liu Y
    Oncol Rep; 2017 Apr; 37(4):2237-2244. PubMed ID: 28350087
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo.
    Liu X; Song M; Wang P; Zhao R; Chen H; Zhang M; Shi Y; Liu K; Liu F; Yang R; Li E; Bode AM; Dong Z; Lee MH
    Int J Cancer; 2019 Aug; 145(4):1007-1019. PubMed ID: 30887517
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GSK3β inhibition suppresses the hepatic lipid accumulation in Schizothorax prenanti.
    Wang Y; Zhan X; Luo W; Zhao L; Yang S; Chen D; Li Z; Wang L
    Fish Physiol Biochem; 2019 Dec; 45(6):1953-1961. PubMed ID: 31401708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RND1 is up-regulated in esophageal squamous cell carcinoma and promotes the growth and migration of cancer cells.
    Xiang G; Yi Y; Weiwei H; Weiming W
    Tumour Biol; 2016 Jan; 37(1):773-9. PubMed ID: 26250459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.